Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders

NCT02472509 is registered in ClinicalTrials.gov with Shaare Zedek Medical Center as lead sponsor.

NCT NCT02472509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02472509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders
Lead sponsor
Shaare Zedek Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2014
Completion date
September 10, 2017
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gallstones, hemolytic disorders